免责声明: 本站汇总 FDA、ClinicalTrials.gov、PubMed、SEC EDGAR 等官方公开数据,仅供一般参考,不构成医疗建议、诊断、治疗建议或投资建议。

FDA 510(k)

Straumann® BLC植入物 - 指征扩大

K号: K252168 · 2026-03-10

决定日期2026-03-10
产品代码DZE
咨询委员会DE 请注意,您没有提供具体的医疗设备监管文本内容,因此我无法进行翻译。请提供需要翻译的具体文本,我将根据您的要求进行翻译。
决定实质等同

器械摘要

Straumann® BLC Implants - Indication Widening is the device name listed in this FDA 510(k) record. The listed applicant is Institut Straumann AG. It received FDA 510(k) clearance on 2026-03-10 under 510(k) number K252168. The device is classified under product code DZE. It was reviewed by the DE advisory panel. FDA Decision: Substantially Equivalent.

常见问题

What is the Straumann® BLC Implants - Indication Widening?

Straumann® BLC Implants - Indication Widening is a medical device that received FDA 510(k) clearance on 2026-03-10. The listed applicant is Institut Straumann AG. The 510(k) number is K252168.

When did Straumann® BLC Implants - Indication Widening receive FDA 510(k) clearance?

Straumann® BLC Implants - Indication Widening received FDA 510(k) clearance on 2026-03-10, under 510(k) number K252168.

Who is the listed applicant for Straumann® BLC Implants - Indication Widening?

The FDA 510(k) record lists Institut Straumann AG as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for Straumann® BLC Implants - Indication Widening?

The FDA product code for Straumann® BLC Implants - Indication Widening is DZE.

相关临床试验

关联记录通过名称、产品代码或其他元数据自动匹配。匹配不意味着已验证临床、科学、企业或监管关系;请查阅链接的官方来源。

列明Institut Straumann AG为申报人的其他记录

关联记录通过名称、产品代码或其他元数据自动匹配。匹配不意味着已验证临床、科学、企业或监管关系;请查阅链接的官方来源。

查看所有 57 个设备 →

相关器械(代码:DZE)

关联记录通过名称、产品代码或其他元数据自动匹配。匹配不意味着已验证临床、科学、企业或监管关系;请查阅链接的官方来源。

官方来源

在 FDA 数据库中查看 →

数据来源于FDA开放API。如需最新且权威的信息,请务必参考官方记录。

↑